TickerTain
TickerTain
NewsroomShortsPortfolioConvergence
NewsroomShortsPortfolioConvergence
←
▶ 39:00 · AI in Healthcare · AI operating system cuts clinical trial timelines by 50% via protocol automation
episode briefing
SeedRocket TV

Cómo escalar una startup de SALUD desde España al mundo | Pedro Coelho - La historia de BIORCE

2026-02-18 · 1 company · 3 thematic
sentiment
1 bull0 bear0 neu
speakers
pedro coelho

Portuguese entrepreneur who built and sold a chicken export business in Poland, then founded a clinical trial CRO in London (sold to Dutch PE), then founded Biorce in Barcelona to automate clinical trials with AI. Holds Oxford Medical School admission but chose business. Raised $52.5M Series A from DST Global and Norsken after 0-$10M ARR in 9 months.

now playing · AI in Healthcare
AI in Healthcaretailwindscore 8/10pedro coelho
AI operating system cuts clinical trial timelines by 50% via protocol automation
Biorce's AI platform trained on 1M+ clinical trials automates protocol drafting (90 seconds vs 8 months), hospital selection, and contract negotiation, targeting the 40% 'white space' betwe…
AI Infrastructuretailwindscore 7/10pedro coelho
High compute spend per prompt (50x OpenAI) ensures accuracy in regulated clinical AI
Biorce spends 50x more compute per prompt than OpenAI to achieve clinical-grade accuracy, running multiple inference passes and human-in-the-loop review. This architecture pattern may gener…
Medical Imaging & Diagnosticstailwindscore 7/10pedro coelho
Liquid biopsies and preventive testing to replace costly MRI-based screening
Preventive health shifts from reactive to proactive using liquid biopsies and multi-marker blood tests, democratizing access vs expensive MRI machines with long waitlists. This enables earl…